Board Meetings for BALPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| BALPHARMA | Bal Pharma Limited | 30 May 2017 | Results/Dividend | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 30, 2017 Inter alia, Considering approval of audited stand alone and consolidated financial results of the Company for the financial year 2016. The Company has now informed the Exchange that the Board inter alia will also be considering recommendation of Dividend for the financial year 2016.17,(Purpose Revised). | |
| BALPHARMA | Bal Pharma Limited | 07 Feb 2017 | Results | To inter alia take on record and approve the Un-Audited financial results of the Company for the quarter ended December 31, 2016. Further, pursuant to Prohibition of Insider Trading Regulations,2015 of SEBI and as per the provisions of Code of Conduct of the Company, the trading window on the designated employees of the Company and their immediate relatives shall remain closed from January 25, 2017 up to February 08, 2017. . | |
| BALPHARMA | Bal Pharma Limited | 14 Nov 2016 | Results | Inter alia take on record and approve the Un-Audited financial results of the Company for the quarter and half year ended September 30, 2016. | |
| BALPHARMA | Bal Pharma Limited | 10 Aug 2016 | Results/Others | Sub : The Board of Directors inter alia will be transacting the following business. (1.) To take on record and approve the Un-audited financial results of the Company for the quarter ended June 30, 2016. (2).To approve the AGM Notice , Directors Report and Corporate Governance reports of the Company for the financial year ended March 31, 2016. (3). To decided on the Book closure dates for Financial Year 2015-16. 4. To consider other AGM related matters. 5. To consider certain key business propositions. | |
| BALPHARMA | Bal Pharma Limited | 25 May 2016 | Results/Dividend | Inter alia will be transacting the following business,1. To take on record and approve the audited financial results of the Company for the financial year ended March 31, 2016.2. Appropriation of profits including recommendation of dividend if any, for the F.Y 2015.16.3. To consider various other A.G.M related aspects. | |
| BALPHARMA | Bal Pharma Limited | 13 Apr 2016 | Allotment of Securities | Inter alia, to consider allotment of equity shares to the investors upon conversion of warrants. | |
| BALPHARMA | Bal Pharma Limited | 10 Feb 2016 | Results | inter alia will be taking on record and approve the unaudited financial results of the Company for the quarter ended December 31, 2015. | |
| BALPHARMA | Bal Pharma Limited | 09 Nov 2015 | Results | inter alia will be considering taking on record and approval of Un-audited financial results of the Company for the quarter and half year ended September 30, 2015. | |
| BALPHARMA | Bal Pharma Limited | 13 Aug 2015 | Results/Others | Inter alia will be transacting the following business, 1. To take on record and approve the Un-audited financial results of the Company for the 1st quarter ended June 30, 2015. 2. Fixing of Book closure and Annual General Meeting dates. 3. Other AGM related matters. | |
| BALPHARMA | Bal Pharma Limited | 29 May 2015 | Results/Dividend | The Board Inter alia will be transacting the following business, 1. Consideration of the Audited Financial Results of the Company for the 4th quarter and financial year ended on March 31, 2015. 2. Appropriation of profits including recommendation of Dividend, if any. | |
| BALPHARMA | Bal Pharma Limited | 12 Feb 2015 | Results | inter considering taking on record and approval of Un-Audited financial results of the Company for the quarter ended December 31, 2014. | |
| BALPHARMA | Bal Pharma Limited | 08 Nov 2014 | Results | Inter alia will be taking on record and approve the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2014. | - |
| BALPHARMA | Bal Pharma Limited | 20 Oct 2014 | Allotment of Securities | The Board of Directors inter alia will consider issue and allotment of warrants to the investors on preferential basis. | - |
| BALPHARMA | Bal Pharma Limited | 11 Aug 2014 | Results/Others | for considering inter alia Un-Audited Financial results for the quarter ended 30.06.2014, & also proposal for preferential issue of securities will also be taken up for consideration by the Board at the said meeting. (purpose revised) | - |
| BALPHARMA | Bal Pharma Limited | 11 Aug 2014 | Results | inter alia will be taking on record and approve the Un-Audited financial results of the Company for the quarter ended June 30, 2014. | - |